APOE and Parkinson disease: In PD, APOE4 carriers are significantly more prevalent among those with PDD, with a 20–35% higher prevalence than in HCs and PD-NC subjects (Parsian et al., 2002; Williams-Gray et al., 2009; Tsuang et al., 2013).